(PNNT) PennantPark Investment - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7080621045
Stock: Mezzanine Debt, Senior Secured Loans, Equity Investments
Total Rating 19
Risk 57
Buy Signal -1.19
| Risk 5d forecast | |
|---|---|
| Volatility | 21.6% |
| Relative Tail Risk | 0.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.76 |
| Alpha | -29.36 |
| Character TTM | |
|---|---|
| Beta | 0.496 |
| Beta Downside | 0.964 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.99% |
| CAGR/Max DD | 0.41 |
EPS (Earnings per Share)
Revenue
Description: PNNT PennantPark Investment February 25, 2026
PennantPark Investment Corporation (NYSE: PNNT) is a Business Development Company that focuses on direct and mezzanine financing for U.S. middle-market companies. It deploys capital across the capital structure-senior secured loans, subordinated debt, mezzanine loans, and equity-targeting investments of $10 million to $100 million in firms with EBITDA of $10 million-$50 million and revenues of $50 million-$1 billion.
As of the most recent quarter, PNNT reported a net asset value (NAV) of $1.02 billion and generated a 7.4% distribution yield, reflecting its emphasis on higher-yielding credit assets. The BDC sector has benefited from a tightening of bank lending to midsize firms, with the U.S. middle-market loan market expanding 5% YoY in Q4 2025, supporting demand for mezzanine and senior secured financing. Additionally, the firm’s exposure to technology and healthcare services aligns with sector growth rates of 8% and 6% respectively, driven by ongoing digital transformation and aging demographics.
For a deeper dive into PNNT’s valuation metrics and how it fits within the broader BDC landscape, you might want to explore ValueRay’s research platform.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 25.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 20.95 > 1.0 |
| NWC/Revenue: -158.5% < 20% (prev -21.93%; Δ -136.6% < -1%) |
| CFO/TA 0.21 > 3% & CFO 272.4m > Net Income 25.6m |
| Net Debt (591.6m) to EBITDA (26.1m): 22.65 < 3 |
| Current Ratio: 0.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (64.0m) vs 12m ago -2.04% < -2% |
| Gross Margin: 45.06% > 18% (prev 0.58%; Δ 4449 % > 0.5%) |
| Asset Turnover: 5.92% > 50% (prev 7.94%; Δ -2.03% > 0%) |
| Interest Coverage Ratio: 0.72 > 6 (EBITDA TTM 26.1m / Interest Expense TTM 40.1m) |
Altman Z'' -1.57
| A: -0.10 (Total Current Assets 22.8m - Total Current Liabilities 149.7m) / Total Assets 1.29b |
| B: -0.22 (Retained Earnings -283.3m / Total Assets 1.29b) |
| C: 0.02 (EBIT TTM 28.7m / Avg Total Assets 1.35b) |
| D: -0.34 (Book Value of Equity -283.3m / Total Liabilities 836.3m) |
| Altman-Z'' Score: -1.57 = D |
Beneish M
| DSRI: 0.13 (Receivables 5.18m/58.0m, Revenue 80.0m/112.2m) |
| GMI: 1.28 (GM 45.06% / 57.76%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.71 (Revenue 80.0m / 112.2m) |
| TATA: -0.19 (NI 25.6m - CFO 272.4m) / TA 1.29b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of PNNT shares?
As of March 05, 2026, the stock is trading at USD 5.09 with a total of 599,729 shares traded.
Over the past week, the price has changed by -0.97%, over one month by -10.55%, over three months by -7.96% and over the past year by -17.08%.
Over the past week, the price has changed by -0.97%, over one month by -10.55%, over three months by -7.96% and over the past year by -17.08%.
Is PNNT a buy, sell or hold?
PennantPark Investment has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold PNNT.
- StrongBuy: 1
- Buy: 0
- Hold: 6
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the PNNT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.5 | 8.1% |
| Analysts Target Price | 5.5 | 8.1% |
PNNT Fundamental Data Overview March 05, 2026
P/E Trailing = 12.9744
P/E Forward = 9.0744
P/S = 2.8625
P/B = 0.7255
P/EG = 0.279
Revenue TTM = 80.0m USD
EBIT TTM = 28.7m USD
EBITDA TTM = 26.1m USD
Long Term Debt = 459.6m USD (estimated: total debt 609.3m - short term 149.7m)
Short Term Debt = 149.7m USD (from shortTermDebt, last quarter)
Debt = 609.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 591.6m USD (from netDebt column, last quarter)
Enterprise Value = 922.0m USD (330.4m + Debt 609.3m - CCE 17.7m)
Interest Coverage Ratio = 0.72 (Ebit TTM 28.7m / Interest Expense TTM 40.1m)
EV/FCF = 3.39x (Enterprise Value 922.0m / FCF TTM 272.4m)
FCF Yield = 29.54% (FCF TTM 272.4m / Enterprise Value 922.0m)
FCF Margin = 340.4% (FCF TTM 272.4m / Revenue TTM 80.0m)
Net Margin = 31.99% (Net Income TTM 25.6m / Revenue TTM 80.0m)
Gross Margin = 45.06% ((Revenue TTM 80.0m - Cost of Revenue TTM 44.0m) / Revenue TTM)
Gross Margin QoQ = 47.21% (prev 8.46%)
Tobins Q-Ratio = 0.71 (Enterprise Value 922.0m / Total Assets 1.29b)
Interest Expense / Debt = 1.72% (Interest Expense 10.5m / Debt 609.3m)
Taxrate = 6.99% (673.0k / 9.63m)
NOPAT = 26.7m (EBIT 28.7m * (1 - 6.99%))
Current Ratio = 0.15 (Total Current Assets 22.8m / Total Current Liabilities 149.7m)
Debt / Equity = 1.33 (Debt 609.3m / totalStockholderEquity, last quarter 457.2m)
Debt / EBITDA = 22.65 (Net Debt 591.6m / EBITDA 26.1m)
Debt / FCF = 2.17 (Net Debt 591.6m / FCF TTM 272.4m)
Total Stockholder Equity = 472.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.89% (Net Income 25.6m / Total Assets 1.29b)
RoE = 5.42% (Net Income TTM 25.6m / Total Stockholder Equity 472.5m)
RoCE = 3.08% (EBIT 28.7m / Capital Employed (Equity 472.5m + L.T.Debt 459.6m))
RoIC = 2.38% (NOPAT 26.7m / Invested Capital 1.12b)
WACC = 3.76% (E(330.4m)/V(939.7m) * Re(7.74%) + D(609.3m)/V(939.7m) * Rd(1.72%) * (1-Tc(0.07)))
Discount Rate = 7.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.97%
[DCF] Terminal Value 80.82% ; FCFF base≈164.0m ; Y1≈107.7m ; Y5≈49.1m
[DCF] Fair Price = 14.91 (EV 1.57b - Net Debt 591.6m = Equity 973.6m / Shares 65.3m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -21.04 | EPS CAGR: -12.31% | SUE: -4.0 | # QB: 0
Revenue Correlation: 54.55 | Revenue CAGR: 24.51% | SUE: -0.09 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.15 | Chg7d=-0.012 | Chg30d=-0.020 | Revisions Net=-4 | Analysts=8
EPS current Year (2026-09-30): EPS=0.56 | Chg7d=-0.076 | Chg30d=-0.086 | Revisions Net=-5 | Growth EPS=-20.9% | Growth Revenue=-12.1%
EPS next Year (2027-09-30): EPS=0.57 | Chg7d=-0.057 | Chg30d=-0.056 | Revisions Net=-5 | Growth EPS=+2.3% | Growth Revenue=-2.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.2% (Discount Rate 7.9% - Earnings Yield 7.7%)
[Growth] Growth Spread = -9.9% (Analyst -9.7% - Implied 0.2%)
P/E Forward = 9.0744
P/S = 2.8625
P/B = 0.7255
P/EG = 0.279
Revenue TTM = 80.0m USD
EBIT TTM = 28.7m USD
EBITDA TTM = 26.1m USD
Long Term Debt = 459.6m USD (estimated: total debt 609.3m - short term 149.7m)
Short Term Debt = 149.7m USD (from shortTermDebt, last quarter)
Debt = 609.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 591.6m USD (from netDebt column, last quarter)
Enterprise Value = 922.0m USD (330.4m + Debt 609.3m - CCE 17.7m)
Interest Coverage Ratio = 0.72 (Ebit TTM 28.7m / Interest Expense TTM 40.1m)
EV/FCF = 3.39x (Enterprise Value 922.0m / FCF TTM 272.4m)
FCF Yield = 29.54% (FCF TTM 272.4m / Enterprise Value 922.0m)
FCF Margin = 340.4% (FCF TTM 272.4m / Revenue TTM 80.0m)
Net Margin = 31.99% (Net Income TTM 25.6m / Revenue TTM 80.0m)
Gross Margin = 45.06% ((Revenue TTM 80.0m - Cost of Revenue TTM 44.0m) / Revenue TTM)
Gross Margin QoQ = 47.21% (prev 8.46%)
Tobins Q-Ratio = 0.71 (Enterprise Value 922.0m / Total Assets 1.29b)
Interest Expense / Debt = 1.72% (Interest Expense 10.5m / Debt 609.3m)
Taxrate = 6.99% (673.0k / 9.63m)
NOPAT = 26.7m (EBIT 28.7m * (1 - 6.99%))
Current Ratio = 0.15 (Total Current Assets 22.8m / Total Current Liabilities 149.7m)
Debt / Equity = 1.33 (Debt 609.3m / totalStockholderEquity, last quarter 457.2m)
Debt / EBITDA = 22.65 (Net Debt 591.6m / EBITDA 26.1m)
Debt / FCF = 2.17 (Net Debt 591.6m / FCF TTM 272.4m)
Total Stockholder Equity = 472.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.89% (Net Income 25.6m / Total Assets 1.29b)
RoE = 5.42% (Net Income TTM 25.6m / Total Stockholder Equity 472.5m)
RoCE = 3.08% (EBIT 28.7m / Capital Employed (Equity 472.5m + L.T.Debt 459.6m))
RoIC = 2.38% (NOPAT 26.7m / Invested Capital 1.12b)
WACC = 3.76% (E(330.4m)/V(939.7m) * Re(7.74%) + D(609.3m)/V(939.7m) * Rd(1.72%) * (1-Tc(0.07)))
Discount Rate = 7.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.97%
[DCF] Terminal Value 80.82% ; FCFF base≈164.0m ; Y1≈107.7m ; Y5≈49.1m
[DCF] Fair Price = 14.91 (EV 1.57b - Net Debt 591.6m = Equity 973.6m / Shares 65.3m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -21.04 | EPS CAGR: -12.31% | SUE: -4.0 | # QB: 0
Revenue Correlation: 54.55 | Revenue CAGR: 24.51% | SUE: -0.09 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.15 | Chg7d=-0.012 | Chg30d=-0.020 | Revisions Net=-4 | Analysts=8
EPS current Year (2026-09-30): EPS=0.56 | Chg7d=-0.076 | Chg30d=-0.086 | Revisions Net=-5 | Growth EPS=-20.9% | Growth Revenue=-12.1%
EPS next Year (2027-09-30): EPS=0.57 | Chg7d=-0.057 | Chg30d=-0.056 | Revisions Net=-5 | Growth EPS=+2.3% | Growth Revenue=-2.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.2% (Discount Rate 7.9% - Earnings Yield 7.7%)
[Growth] Growth Spread = -9.9% (Analyst -9.7% - Implied 0.2%)